Updated picture of SARS-CoV-2 variants and mutations
The worldwide burden of coronavirus disease 2019 (COVID-19) is still unremittingly
prosecuting, with nearly 300 million infections and over 5.3 million deaths recorded so far …
prosecuting, with nearly 300 million infections and over 5.3 million deaths recorded so far …
SARS-CoV-2: an update on the biological interplay with the human host
Coronavirus Disease 2019 (COVID-19) is an infectious respiratory illness caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease, first identified in the …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease, first identified in the …
Predicting COVID-19 disease severity from SARS-CoV-2 spike protein sequence by mixed effects machine learning
BA Sokhansanj, GL Rosen - Computers in biology and medicine, 2022 - Elsevier
Epidemiological studies show that COVID-19 variants-of-concern, like Delta and Omicron,
pose different risks for severe disease, but they typically lack sequence-level information for …
pose different risks for severe disease, but they typically lack sequence-level information for …
Interpretable and predictive deep neural network modeling of the SARS-Cov-2 spike protein sequence to predict COVID-19 disease severity
BA Sokhansanj, Z Zhao, GL Rosen - Biology, 2022 - mdpi.com
Simple Summary As COVID-19 shifts from pandemic to endemic, emerging variants may be
more or less virulent. Predicting whether an emerging COVID-19 variant has of high risk of …
more or less virulent. Predicting whether an emerging COVID-19 variant has of high risk of …
Evaluating the transmission feasibility of SARS-CoV-2 Omicron (B. 1.1. 529) variant to 143 mammalian hosts: insights from S protein RBD and host ACE2 interaction …
In comparison to previously known severe respiratory syndrome coronavirus 2 (SARS-CoV-
2) variants, the newly emerged Omicron (B. 1.1. 529) variant shows higher infectivity in …
2) variants, the newly emerged Omicron (B. 1.1. 529) variant shows higher infectivity in …
Safety and immunogenicity of COVID-19 BBIBP-CorV vaccine in children 3–12 years old
Background and Objectives: In the current COVID-19 pandemic, children below the age of
12 could manifest COVID-19 symptoms and serve as a reservoir for the virus in the …
12 could manifest COVID-19 symptoms and serve as a reservoir for the virus in the …
Interpretable and predictive deep modeling of the SARS-CoV-2 spike protein sequence
As the COVID-19 pandemic continues, the SARS-CoV-2 virus continues to rapidly mutate
and change in ways that impact virulence, transmissibility, and immune evasion. Genome …
and change in ways that impact virulence, transmissibility, and immune evasion. Genome …
Phylogenetic analysis and comparative genomics of SARS-CoV-2 from survivor and non-survivor COVID-19 patients in Cordoba, Argentina
NB Olivero, AS Gonzalez-Reiche, VE Re, GM Castro… - BMC genomics, 2022 - Springer
Abstract Background The SARS-CoV-2 virus is responsible for the COVID-19 pandemic. To
better understand the evolution of SARS-CoV-2 early in the pandemic in the Province of …
better understand the evolution of SARS-CoV-2 early in the pandemic in the Province of …
Phylogeogenomic analysis of the earliest reported sequences of SARS‐CoV‐2 from 161 countries
The SARS‐CoV‐2 is the causative agent of COVID‐19 whose evolutionary path with
geographical context forms the focus of present study. The first reported sequence from each …
geographical context forms the focus of present study. The first reported sequence from each …
[HTML][HTML] Genetic path of the emergence of SARS-CoV-2
Context: Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) is the seventh
coronavirus that has humans as the host. Because of its highly infectious nature, toward the …
coronavirus that has humans as the host. Because of its highly infectious nature, toward the …